Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedRevision note added: v3.4.2 replaces v3.4.1. This update does not alter study details or page behavior.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded Revision: v3.4.1 and removed the prior government-funding lapse notice (Revision: v3.4.0).SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedUI/text updates were added: Show glossary, No FEAR Act Data, and Revision: v3.4.0. The previous labels such as 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4' were removed or updated.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor backend/version update with no changes to trial details, eligibility criteria, or results visible to users. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedLocations now lists many new sites across multiple regions and countries, replacing prior location groupings. The update broadens the geographic coverage of trial sites.SummaryDifference2%

- Check83 days agoChange DetectedRevision: v3.3.2 has been applied, and there are no changes to the trial details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.